STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Short Interest Up 48.6% in October

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) saw a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 5,500 shares, an increase of 48.6% from the October 15th total of 3,700 shares. Based on an average daily trading volume, of 12,500 shares, the short-interest ratio is currently 0.4 days. Currently, 0.2% of the company’s stock are short sold.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in STRATA Skin Sciences stock. Azzad Asset Management Inc. ADV acquired a new stake in STRATA Skin Sciences, Inc. (NASDAQ:SSKN) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 12,000 shares of the medical device company’s stock, valued at approximately $33,000. Azzad Asset Management Inc. ADV owned about 0.34% of STRATA Skin Sciences as of its most recent SEC filing. 32.43% of the stock is owned by institutional investors.

STRATA Skin Sciences Stock Down 2.9 %

Shares of STRATA Skin Sciences stock traded down $0.09 during trading hours on Friday, hitting $3.01. 5,058 shares of the company’s stock traded hands, compared to its average volume of 12,246. The company has a quick ratio of 0.92, a current ratio of 1.14 and a debt-to-equity ratio of 1.59. STRATA Skin Sciences has a twelve month low of $2.51 and a twelve month high of $6.96. The stock has a 50 day simple moving average of $3.01 and a 200-day simple moving average of $3.23. The company has a market cap of $12.55 million, a PE ratio of -1.13 and a beta of 1.32.

STRATA Skin Sciences (NASDAQ:SSKN) last announced its earnings results on Wednesday, August 14th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter. The business had revenue of $8.44 million during the quarter. STRATA Skin Sciences had a negative net margin of 28.72% and a negative return on equity of 67.36%. Equities research analysts anticipate that STRATA Skin Sciences will post -1 earnings per share for the current fiscal year.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.